TrialActa haematologica2025

Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII.

Mark T Reding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.